09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
Robinson+Cole’s Construction Group is pleased to bring you a recap of posts from our Construction L...
Read More >
On October 23, 2019, the Department of Labor (DOL) published a proposed rule that, if finalized in i...
Read More >
As part of our ongoing series on the final regulations expanding the availability of health reimburs...
Read More >
Seyfarth Synopsis: On Tuesday, the Third Circuit issued a decision rejecting the U.S. DOL’s general...
Read More >
It seems like we’ve discussed this subject for years. It was May of 2016 when the Obama DOL issued ...
Read More >
The Illinois legislature engaged in a flurry of recent activity in the area of employee protections....
Read More >